These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 15492200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M.
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract] [Full Text] [Related]

  • 3. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E, Ermertcan AT, Bilaç C, Bilaç DB, Temiz P.
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [Abstract] [Full Text] [Related]

  • 4. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM.
    Dermatol Nurs; 2009 Dec; 21(2):86-7. PubMed ID: 19507375
    [Abstract] [Full Text] [Related]

  • 5. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
    Quirk C, Gebauer K, Owens M, Stampone P.
    Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients.
    Vidal D, Alomar A.
    Clin Exp Dermatol; 2004 May; 29(3):237-9. PubMed ID: 15115500
    [Abstract] [Full Text] [Related]

  • 7. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
    Yang JQ, Chen XY, Engle MY, Wang JY.
    Dermatol Ther; 2015 May; 28(4):243-7. PubMed ID: 25754701
    [Abstract] [Full Text] [Related]

  • 8. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P, Monsieur E, Petein M, Heenen M.
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
    Ruiz-Villaverde R, Sánchez-Cano D, Burkhardt-Pérez P.
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
    [Abstract] [Full Text] [Related]

  • 11. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
    Ezughah FI, Affleck AG, Evans A, Ibbotson SH, Fleming CJ.
    J Dermatolog Treat; 2008 Jul; 19(3):156-8. PubMed ID: 18569271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod.
    Scott DR.
    J Drugs Dermatol; 2004 Jul; 3(6):602. PubMed ID: 15624742
    [No Abstract] [Full Text] [Related]

  • 14. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Tebbs V, McRae S.
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
    Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, Ding L, Thissen MR.
    Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
    Warshauer E, Warshauer BL.
    J Drugs Dermatol; 2008 May; 7(5):447-51. PubMed ID: 18505136
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.